Vnitr Lek 2005, 51(1):72-75

Obesity and metabolic syndrome

D. Zeman
II. interní klinika Lékařské fakulty MU a FN u sv. Anny, Brno, přednosta doc. MUDr. Miroslav Souček, CSc.

Obesity is associated with insulinresistance and metabolic syndrome. The correlation of the presence of abdominal or visceral obesity defined by waist circumference with the occurence of metabolic risk factors and metabolic syndrome is more significant than body mass index. Adipocytokine secretion activity of adipose tissue participates in the pathogenesis of metabolic syndrome. External factors can significantly modify the course of metabolic syndrome disease. Weight reduction is an effective therapeutical intervention. Complex therapeutical approach includes the cognitive behavioral intervention techniques, dietotherapy, regimen exercise measures, pharmacotherapy and surgical bariatric techniques.

Keywords: obesity; visceral obesity; adipose tissue; metabolic syndrome; therapy, treatment of obesity

Received: February 28, 2004; Accepted: July 15, 2004; Published: January 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zeman D. Obesity and metabolic syndrome. Vnitr Lek. 2005;51(1):72-75.
Download citation

References

  1. Abate N, Garg A. Heterogenity in tissue metabolism: causes, implications and management of regional adiposity. Prog Lipid Res 1995; 34: 53-70. Go to original source... Go to PubMed...
  2. Gray GB. Obesity is a chronic, relapsing neurochemical disease. International Journal of Obesity 2004; 28: 34-38. Go to original source... Go to PubMed...
  3. Hainer V, Kunešová M. Obezita. Praha: Galén 1997.
  4. Kissebah AH, Krakower FR. Regional adiposity and morbidity. Physiol Rev 1994; 74: 761-811. Go to original source... Go to PubMed...
  5. Muredach PR, Daniel J. The Metabolic Syndrom: More Than the Sum of Its parts? Circulation 2003;108: 1546-1551. Go to original source... Go to PubMed...
  6. Nives DJ, Cnop M et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 2003: 52: 172-179. Go to original source... Go to PubMed...
  7. Peter WF, Scott MG. The Metabolic Syndrom. Practical Guide to Originis and Treatment. Part I. Circulation 2003; 108: 1422-1425. Go to original source... Go to PubMed...
  8. Scott MG, Brewer BH et al. Definition of Metabolic Syndrome, Report of the National Heart, Lung, and Blood Institute/AHA Conference on Scientific Issues Related to Definition. Circulation 2004; 109: 433-438. Go to original source... Go to PubMed...
  9. Scott MG, Hansen B et al. Clinical Management of Metabolic Syndrom, Report of the AHA/National Heart, Lung, and Blood Institute/ADA Conference on Scientific Issues Related to Management. Circulation 2004; 109: 551-556. Go to original source... Go to PubMed...
  10. Svačina S, Owen K. Syndrom inzulinové rezistence. Praha: Triton 2003.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.